Merck KGaA’s 2017 Swiss cancer spin-out iOnctura SA has raised €15m to bring its PI3Kδ inhibitor and autotaxin...
Up To Date
Latest News
Ministers from 72 countries came together at the Berlin Agriculture Ministers’ conference to discuss and adopt...
HepaRegeniX has raised €11m in a Series B. The biotech company will use the proceeds to bring its compound...
Swiss food giant Nestlé will invest up to €1.68bn to support sustainable packaging solutions and to create a...
mRNA cancer neoantigen specialist BioNTech AG is set to buy all shares of Neon Therapeutics, Inc. expanding...
British researchers have identified several small molecule drugs that sensitized B cell cancers to...
Share
